Published in Am J Kidney Dis on December 01, 1995
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers. J Funct Biomater (2017) 0.75
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75
Quantitation of thermography in arthritis using multi-isothermal analysis. I. The thermographic index. Ann Rheum Dis (1974) 3.82
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med (1998) 3.59
Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int (2008) 2.41
Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology (2000) 2.41
Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol (2001) 2.35
Temperature and biochemical studies of joint inflammation. A preliminary investigation. Ann Rheum Dis (1970) 2.15
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol (1999) 2.04
False positives and negatives in routine testing for drugs of abuse. Lancet (1995) 2.02
Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl (2006) 1.88
Isolation, characterisation and mapping of simple sequence repeat loci in potato. Mol Gen Genet (1998) 1.88
Radioimmunoassay for prednisolone. Steroids (1973) 1.81
Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 1.69
Quantitative thermography. Rheumatol Phys Med (1970) 1.67
Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis (2000) 1.55
Anaemia in patients with arthritis: are simple investigations helpful? Br J Rheumatol (1988) 1.53
Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol (2001) 1.51
Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol (1987) 1.51
Measurement of inflammation in man and animals by radiometry. Br J Pharmacol (1972) 1.49
Surrogate biochemical markers: precise measurement for strategic drug and biologics development. J Clin Pharmacol (1995) 1.43
Failed retrieval of an inferior vena cava filter during pregnancy because of filter tilt: report of two cases. Cardiovasc Intervent Radiol (2008) 1.42
Quantitation of thermography in arthritis using multi-isothermal analysis. II. Effect of nonsteroidal anti-inflammatory therapy on the thermographic index. Ann Rheum Dis (1974) 1.40
Estimating the accumulation of drugs. J Pharm Sci (1983) 1.37
Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol (1999) 1.35
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Clin Pharmacol Ther (1985) 1.34
The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) (2000) 1.33
Pyomyositis: characteristics at CT and MR imaging. Radiology (1995) 1.27
Prostaglandin synthetase activity from human rheumatoid synovial microsomes. Effect of 'aspirin-like' drug therapy. Ann Rheum Dis (1976) 1.27
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis. Am J Kidney Dis (1987) 1.23
Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease. Clin Pharmacol Ther (1992) 1.23
Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers. Br J Clin Pharmacol (2000) 1.23
Lysosomal enzyme levels in the blood of arthritic rats. Biochem Pharmacol (1971) 1.21
Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med (1981) 1.21
Trends in anemia at initiation of dialysis in the United States. Kidney Int (2001) 1.19
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int (1999) 1.18
A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis (1995) 1.14
Whole-bowel irrigation as a treatment for acute lithium overdose. Ann Emerg Med (1991) 1.14
Disposition of the cephalosporin cefepime in normal and renally impaired subjects. Drug Metab Dispos (1991) 1.13
Simultaneous pharmacokinetic and pharmacodynamic modeling. J Pharmacokinet Biopharm (1981) 1.13
Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther (1987) 1.13
Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm (1977) 1.12
Plasma protein binding of diazepam after a single dose of sodium oleate. J Pharm Sci (1978) 1.10
Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med (1997) 1.09
A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis. Br J Clin Pharmacol (1978) 1.09
Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis (1994) 1.08
Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther (1990) 1.07
Mammography screening. N Z Med J (1994) 1.07
Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int (2006) 1.05
Pharmacokinetic/pharmacodynamic modeling in drug research and development. J Clin Pharmacol (2000) 1.04
Pharmacokinetics of erythromycin on repetitive dosing. J Clin Pharmacol (1977) 1.04
Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis (2001) 1.01
Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int (2007) 0.99
Disposition of gabapentin in anuric subjects on hemodialysis. J Clin Pharmacol (1995) 0.99
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1984) 0.99
Application of two microsatellite sequences in wheat storage proteins as molecular markers. Theor Appl Genet (1995) 0.98
Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int (1996) 0.98
The effect of pH on the production of prostaglandins E 2 and F 2alpha, and a possible pH dependent inhibitor. Prostaglandins (1974) 0.98
Interaction of chloramphenicol with phenytoin and phenobarbital. Case report. Clin Pharmacol Ther (1978) 0.98
Dose dependent pharmacokinetics of midazolam. Eur J Clin Pharmacol (1985) 0.97
Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro. Ann Rheum Dis (1977) 0.97
A comparison of the effect of flurbiprofen on prostaglandin synthetase from human rheumatoid synovium and enzymatically active animal tissues. J Pharm Pharmacol (1976) 0.96
Food increases the bioavailability of isotretinoin. J Clin Pharmacol (1984) 0.96
The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs. Br J Rheumatol (1986) 0.96
Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther (1990) 0.96
Low birth weight is associated with chronic kidney disease only in men. Kidney Int (2007) 0.95
Longitudinal evaluation of bovine mammary gland health status by somatic cell counting, flow cytometry, and cytology. J Vet Diagn Invest (2001) 0.95
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Am J Nephrol (1985) 0.95
Disposition of vancomycin during hemofiltration. Clin Pharmacol Ther (1986) 0.93
Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats. Antimicrob Agents Chemother (1998) 0.93
Method for the determination of acemetacin, a non-steroidal anti-inflammatory drug, in plasma by high-performance liquid chromatography. J Chromatogr (1987) 0.92
Ultrasound is now better than mammography for the detection of invasive breast cancer. Am J Surg (2004) 0.92
Electron microscopy of the red pulp of the dog spleen including vascular arrangements, periarterial macrophage sheaths (ellipsoids), and the contractile, innervated reticular meshwork. Am J Anat (1981) 0.92
Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med (1992) 0.92
Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. J Rheumatol (1999) 0.91
Renal clearance of carprofen in the isolated perfused rat kidney. Drug Metab Dispos (1981) 0.91
Behavior problems and social competence in girls with true precocious puberty. J Pediatr (1985) 0.91
Structured approach to the investigation of anaemia in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.90
Thermography and radiology complimentary methods for the study of inflammatory diseases. Clin Radiol (1976) 0.89
Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection. J Chromatogr (1987) 0.88
5-Azacytidine and renal tubular dysfunction. Blood (1981) 0.88
Posterior interosseous nerve compression due to an enlarged bicipital bursa confirmed by MRI. J Hand Surg Br (1993) 0.88
Pharmacokinetic model for diazepam and its major metabolite desmethyldiazepam following diazepam administration. J Pharm Sci (1983) 0.88
Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteers. J Clin Pharmacol (1987) 0.88
The effect of adrenergic blockade in hypertrophic pulmonary osteoarthropathy (HPOA). Postgrad Med J (1976) 0.87
An evolution of drug development and clinical pharmacology during the 20th century. J Clin Pharmacol (2000) 0.87
Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival. Am J Kidney Dis (1988) 0.87
Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene. Clin Pharmacol Ther (1982) 0.87
Cell electrophoretic analysis of lymphocytes and polymorphonuclear cells from patients with rheumatoid arthritis. Lancet (1977) 0.87
Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease. Clin Pharmacol Ther (1988) 0.87
Social cognitions as organizers of autonomic and affective responses to social challenge. J Pers Soc Psychol (1993) 0.87
Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses. J Clin Pharmacol (1988) 0.86
Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy. Br J Rheumatol (1986) 0.86
Breast cancer audit: adapting national audit frameworks for local review of clinical practice. Health Bull (Edinb) (2001) 0.86
Impact of disease severity and hematocrit level on reuse-associated mortality. Am J Kidney Dis (2000) 0.86
The clinical pharmacokinetics of quinapril. Angiology (1989) 0.86
Disposition of cefpodoxime proxetil in hemodialysis patients. J Clin Pharmacol (1992) 0.85